International Journal of Pancreatology

, Volume 11, Issue 3, pp 185–189 | Cite as

Effect of SMS 201-995 on exocrine pancreatic secretion in a patient with external pancreatic fistula

  • Tetsuo Ohta
  • Takukazu Nagakawa
  • Kazuhiro Mori
  • Masahiro Kanno
  • Masato Kayahara
  • Keiichi Ueno
  • Itsuo Miyazaki


The effect of SMS 201-995 on pancreatic exocrine function was studied. The SMS 201-995 was adminis-tered to a patient with an artificial external pancreatic fistula following pancreaticoduodenectomy. Varia-tions in pancreatic exocrine function were assessed by determining the volume and components of the fistula fluid during the following periods: 5 d prior to SMS 201-995 administration, for 5 d during actual administration, and for 5 d after it had been discontinued. The SMS 201-995 was administered by subcu-taneous injection of 100 μg every 12 h for the first 2 d and then 100 μg every 6 h for 3 d. This experiment demonstrated that SMS 201-995 has a strong inhibitory effect on pancreatic exocrine function, markedly reducing the amount of fistula fluid and the production of amylase, total protein, and bicarbonate.

Key Words

A long-acting somatostatin analog SMS 201-995 (Sandostatin®) inhibition of pancreatic exocrine function 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    1Ohta T, Nagakawa T, Koyasaki N, Kadoya N, Mori K, Nakano T, Ueno K, Miyazaki I. A new management for the complete disruption of the pancreatojejunostomy following pancreatoduodenectomy.Jpn J Bil Pane 1991; 12: 595–599.Google Scholar
  2. 2.
    2Bauer W, Briner U, Doepfner W, Haller R, Huguenin R, Marbach P, Petcher TJ, Pless J. A very potent and selective octapeptide analog of somatostatin with prolonged action. Life Sci 1982; 31: 1133–1140.PubMedCrossRefGoogle Scholar
  3. 3.
    3Lembcke B, Creutzfeldt W, Schleser S, Ebert R, Shaw C, Koop I. Effect of the somotostatin analogue sandostatin (SMS 201-995) on gastrointestinal, pancreatic and biliary function and hormone release in normal men.Digestion 1987; 36: 108–124.PubMedCrossRefGoogle Scholar
  4. 4.
    4 Misumi A, Shiratori K, Lee KY, Barkin JS, Chey WY. Effects of SMS 201-995, a somatostatin analogue, on the exocrine pancreatic secretion and gut hormone release in dogs.Surgery 1988; 103: 450–455.PubMedGoogle Scholar
  5. 5.
    5Heij HA, Bruining HA, Verschoor L. A comparison of the effects of two somatostatin analogues in a patient with an external pancreatic fistula.Pancreas 1986; 1: 188–190.PubMedCrossRefGoogle Scholar
  6. 6.
    6Domschke S. Domschke W, Rosch W, Konturek SJ, Sprugel W, Mitznegg P, Wunsch E, Demling L. Inhibition by somatostatin of secretin-stimulated pancreatic secretion in man: A study with pure pancreatic juice.Scand J Gastroenterol 1977; 12: 59–63.PubMedGoogle Scholar
  7. 7.
    7Williams ST, Woltering EA, O’Dorisio TM, Fletcher WS. Effect of octreotide acetate on pancreatic exocrine function.Am J Surg 1989; 157: 459–462.PubMedCrossRefGoogle Scholar
  8. 8.
    Nagakawa T. Improvement technique for pancreatico- jejunostomy after extended pancreaticoduodenectomy.J Jpn Soc Clin Surg 1983; 44: 1000–1003.Google Scholar
  9. 9.
    Guillemin R, Burgus R. The hormones of hypothalamus.Sci Amer 1972; 227: 24.PubMedCrossRefGoogle Scholar
  10. 10.
    Brazeau P, Vale V, Burgus R. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone.Science 1973; 179: 77–79.PubMedCrossRefGoogle Scholar
  11. 11.
    Arimura A, Sato H, Dupont A. Somatostatin: abundance of immunoreactive hormone in rat stomach and pancreas.Science 1975; 189: 1007,1008.PubMedCrossRefGoogle Scholar
  12. 12.
    Lins PE, Efendic S, Hall R. Effect of 24-hours somatostatin infusion on glucose homeostasis and on levels of somatostatin, pancreatic and thyroid hormones in man.Acta Med Scand 1979; 206: 441–445.PubMedGoogle Scholar
  13. 13.
    Bloom SR, Mortimer CH, Thorner MO. Inhibition of gastrin and gastric acid secretion by growth hormone releasing- inhibiting hormone (GH-RIH).Lancet 1974; 2: 1106–1109.PubMedCrossRefGoogle Scholar
  14. 14.
    Boden G, Sivitz MC, Owen OE, Essa-Koumav N, Landon JH. Somatostatin supresses secretin and pancreatic exocrine secretion.Science 1975; 160: 163–165.CrossRefGoogle Scholar
  15. 15.
    Thor P, Krol R, Konturek SJ, Coy DH, Schally AV. Effect of somatostatin on myoelectrical activity of small bowel.Am J Physiol 1978; 235: E249-E254.PubMedGoogle Scholar
  16. 16.
    Bosch J, Kravetz D, Rodes J. Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin.Gastroenterology 1981; 80: 518–525.PubMedGoogle Scholar
  17. 17.
    Mulvihill S, Pappas TN, Passaro E, Debas HT. The use of somatostatin and its analogues in the treatment of surgical disorders.Surgery 1986; 100: 467–476.PubMedGoogle Scholar
  18. 18.
    Nubiola P, Badia JM, Martinez RF. Treatment of 27 postoperative enterocutaneous fistulas with the long half-life somatostatin analogue SMS 201-995.Ann Surg 1989; 210: 56–58.PubMedCrossRefGoogle Scholar
  19. 19.
    Wood SM, Kraenzlin ME, Adrian TE, Bloom SR. Treatment of patients with pancreatic endocrine tumors using a new long-acting somatostatin analogue.Gut 1985; 26: 438–444.PubMedCrossRefGoogle Scholar
  20. 20.
    Seino Y, Nakagawa S, Gotoh Y, Himizu N, Takada R, Saitoh S, Ibayashi H, Imura H. Multicenter clinical trial of SMS 201-995 in gastroenteropancreatic endocrine tumors.Jpn J Hormone and Clinics 1988; 36: 581–590.Google Scholar
  21. 21.
    Shiratori K, Watanabe S, Takeuchi T, Shimizu K, Moriyoshi Y, Cyoh K. Effects of SMS 201-995, long-acting somatostatin analogue, on the exocrine pancreatic secretion and gut hormone release in rats.J Jpn Pan Soc 1990; 5: 227.Google Scholar

Copyright information

© Humana Press Inc. 1992

Authors and Affiliations

  • Tetsuo Ohta
    • 1
  • Takukazu Nagakawa
    • 1
  • Kazuhiro Mori
    • 1
  • Masahiro Kanno
    • 1
  • Masato Kayahara
    • 1
  • Keiichi Ueno
    • 1
  • Itsuo Miyazaki
    • 1
  1. 1.Department of Surgery (II)Kanazawa University School of MedicineKanazawaJapan

Personalised recommendations